HEADER TRANSFERASE 30-SEP-09 2WU6 TITLE CRYSTAL STRUCTURE OF THE HUMAN CLK3 IN COMPLEX WITH DKI COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE CLK3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 127-484; COMPND 5 SYNONYM: CDC-LIKE KINASE 3, CDC-LIKE KINASE 3 ISOFORM HCLK3; COMPND 6 EC: 2.7.12.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: MUSCLE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-R3 KEYWDS TRANSFERASE, KINASE, TYROSINE-PROTEIN KINASE, KEYWDS 2 SERINE/THREONINE-PROTEIN KINASE, NUCLEOTIDE-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR J.R.C.MUNIZ,O.FEDOROV,O.KING,P.FILIPPAKOPOULOS,A.N.BULLOCK,C.PHILLIPS, AUTHOR 2 T.HEIGHTMAN,E.UGOCHUKWU,F.VON DELFT,C.H.ARROWSMITH,A.M.EDWARDS, AUTHOR 3 J.WEIGELT,C.BOUNTRA,S.KNAPP REVDAT 4 07-DEC-11 2WU6 1 AUTHOR JRNL REVDAT 3 13-JUL-11 2WU6 1 VERSN REVDAT 2 02-FEB-10 2WU6 1 KEYWDS REMARK REVDAT 1 20-OCT-09 2WU6 0 JRNL AUTH O.FEDOROV,K.HUBER,A.EISENREICH,P.FILIPPAKOPOULOS,O.KING, JRNL AUTH 2 A.N.BULLOCK,D.SZKLARCZYK,L.J.JENSEN,D.FABBRO,J.TRAPPE, JRNL AUTH 3 U.RAUCH,F.BRACHER,S.KNAPP JRNL TITL SPECIFIC CLK INHIBITORS FROM A NOVEL CHEMOTYPE FOR JRNL TITL 2 REGULATION OF ALTERNATIVE SPLICING. JRNL REF CHEM.BIOL V. 18 67 2011 JRNL REFN ISSN 1074-5521 JRNL PMID 21276940 JRNL DOI 10.1016/J.CHEMBIOL.2010.11.009 REMARK 2 REMARK 2 RESOLUTION. 1.92 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0089 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.92 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 73.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 97.19 REMARK 3 NUMBER OF REFLECTIONS : 28646 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.17215 REMARK 3 R VALUE (WORKING SET) : 0.17000 REMARK 3 FREE R VALUE : 0.21137 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1512 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.920 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.970 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2071 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.08 REMARK 3 BIN R VALUE (WORKING SET) : 0.275 REMARK 3 BIN FREE R VALUE SET COUNT : 109 REMARK 3 BIN FREE R VALUE : 0.336 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2915 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 307 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.837 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.08 REMARK 3 B22 (A**2) : -0.06 REMARK 3 B33 (A**2) : -0.16 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : -0.62 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.155 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.141 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.095 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.153 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3060 ; 0.015 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4135 ; 1.449 ; 1.951 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 355 ; 5.496 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 156 ;33.111 ;23.333 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 524 ;12.938 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;17.130 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 435 ; 0.110 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2336 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1770 ; 0.864 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2869 ; 1.570 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1290 ; 2.700 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1266 ; 4.249 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 134 A 210 REMARK 3 ORIGIN FOR THE GROUP (A): 47.7020 54.0890 16.9340 REMARK 3 T TENSOR REMARK 3 T11: 0.1143 T22: 0.0813 REMARK 3 T33: 0.0352 T12: -0.0671 REMARK 3 T13: -0.0147 T23: 0.0190 REMARK 3 L TENSOR REMARK 3 L11: 1.7117 L22: 0.0545 REMARK 3 L33: 2.0860 L12: 0.1985 REMARK 3 L13: 0.4746 L23: 0.2246 REMARK 3 S TENSOR REMARK 3 S11: -0.0728 S12: 0.0613 S13: -0.0633 REMARK 3 S21: 0.0134 S22: -0.0341 S23: 0.0006 REMARK 3 S31: -0.2148 S32: 0.1021 S33: 0.1068 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 211 A 378 REMARK 3 ORIGIN FOR THE GROUP (A): 26.5970 52.3440 17.8740 REMARK 3 T TENSOR REMARK 3 T11: 0.0962 T22: 0.0597 REMARK 3 T33: 0.0512 T12: -0.0112 REMARK 3 T13: -0.0070 T23: 0.0190 REMARK 3 L TENSOR REMARK 3 L11: 0.8936 L22: 0.1431 REMARK 3 L33: 0.2937 L12: -0.1114 REMARK 3 L13: -0.3263 L23: -0.0823 REMARK 3 S TENSOR REMARK 3 S11: 0.0109 S12: 0.1500 S13: 0.0327 REMARK 3 S21: 0.0164 S22: -0.0350 S23: -0.0352 REMARK 3 S31: -0.0243 S32: -0.0115 S33: 0.0242 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 379 A 483 REMARK 3 ORIGIN FOR THE GROUP (A): 12.2130 49.4520 27.9060 REMARK 3 T TENSOR REMARK 3 T11: 0.0606 T22: 0.0535 REMARK 3 T33: 0.0737 T12: -0.0194 REMARK 3 T13: -0.0043 T23: -0.0112 REMARK 3 L TENSOR REMARK 3 L11: 0.4739 L22: 0.6685 REMARK 3 L33: 1.1949 L12: -0.2830 REMARK 3 L13: -0.3957 L23: 0.2641 REMARK 3 S TENSOR REMARK 3 S11: -0.0605 S12: 0.0892 S13: -0.0064 REMARK 3 S21: 0.0571 S22: -0.0346 S23: 0.1754 REMARK 3 S31: 0.0611 S32: -0.1551 S33: 0.0950 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. U VALUES RESIDUAL ONLY. REMARK 4 REMARK 4 2WU6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-OCT-09. REMARK 100 THE PDBE ID CODE IS EBI-41294. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-APR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9050 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31032 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.92 REMARK 200 RESOLUTION RANGE LOW (A) : 44.32 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 4.3 REMARK 200 R MERGE (I) : 0.05 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.30 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.92 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.4 REMARK 200 R MERGE FOR SHELL (I) : 0.76 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.00 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.4 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M (NH4)2SO4, 0.1M BIS-TRIS REMARK 280 PH 5.5, 25% PEG 3350 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 44.57500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.16500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 44.57500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 31.16500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 104 REMARK 465 HIS A 105 REMARK 465 HIS A 106 REMARK 465 HIS A 107 REMARK 465 HIS A 108 REMARK 465 HIS A 109 REMARK 465 HIS A 110 REMARK 465 SER A 111 REMARK 465 SER A 112 REMARK 465 GLY A 113 REMARK 465 VAL A 114 REMARK 465 ASP A 115 REMARK 465 LEU A 116 REMARK 465 GLY A 117 REMARK 465 THR A 118 REMARK 465 GLU A 119 REMARK 465 ASN A 120 REMARK 465 LEU A 121 REMARK 465 TYR A 122 REMARK 465 PHE A 123 REMARK 465 GLN A 124 REMARK 465 SER A 125 REMARK 465 MET A 126 REMARK 465 GLN A 127 REMARK 465 SER A 128 REMARK 465 SER A 129 REMARK 465 LYS A 130 REMARK 465 ARG A 131 REMARK 465 SER A 132 REMARK 465 SER A 133 REMARK 465 THR A 484 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 140 NZ REMARK 470 GLU A 154 CG CD OE1 OE2 REMARK 470 GLU A 164 CD OE1 OE2 REMARK 470 LYS A 209 CE NZ REMARK 470 LYS A 213 CE NZ REMARK 470 GLU A 214 CG CD OE1 OE2 REMARK 470 LYS A 216 NZ REMARK 470 PHE A 273 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 295 CD OE1 OE2 REMARK 470 GLU A 307 CD OE1 OE2 REMARK 470 LYS A 409 CG CD CE NZ REMARK 470 LYS A 432 CG CD CE NZ REMARK 470 HIS A 483 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 237 O HOH A 2085 1.98 REMARK 500 O1 SO4 A 1487 O HOH A 2305 1.96 REMARK 500 O HOH A 2040 O HOH A 2049 2.19 REMARK 500 O HOH A 2174 O HOH A 2187 2.19 REMARK 500 O HOH A 2201 O HOH A 2203 2.11 REMARK 500 O HOH A 2219 O HOH A 2274 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 155 -50.76 -141.68 REMARK 500 ASN A 215 61.24 35.41 REMARK 500 THR A 282 -12.92 75.53 REMARK 500 ASP A 320 72.51 62.45 REMARK 500 ALA A 336 155.84 77.89 REMARK 500 ALA A 352 -153.42 -154.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKI A1484 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1485 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1486 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1487 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A1488 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A1489 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A1490 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A1491 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A1492 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A1493 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A1494 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1495 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1496 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1497 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2EU9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLK3 REMARK 900 RELATED ID: 2EXE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PHOSPHORYLATED CLK3 REMARK 900 RELATED ID: 2WU7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CLK3 IN REMARK 900 COMPLEX WITH V25 DBREF 2WU6 A 104 126 PDB 2WU6 2WU6 104 126 DBREF 2WU6 A 127 484 UNP P49761 CLK3_HUMAN 127 484 SEQRES 1 A 381 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 381 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLN SER SER SEQRES 3 A 381 LYS ARG SER SER ARG SER VAL GLU ASP ASP LYS GLU GLY SEQRES 4 A 381 HIS LEU VAL CYS ARG ILE GLY ASP TRP LEU GLN GLU ARG SEQRES 5 A 381 TYR GLU ILE VAL GLY ASN LEU GLY GLU GLY THR PHE GLY SEQRES 6 A 381 LYS VAL VAL GLU CYS LEU ASP HIS ALA ARG GLY LYS SER SEQRES 7 A 381 GLN VAL ALA LEU LYS ILE ILE ARG ASN VAL GLY LYS TYR SEQRES 8 A 381 ARG GLU ALA ALA ARG LEU GLU ILE ASN VAL LEU LYS LYS SEQRES 9 A 381 ILE LYS GLU LYS ASP LYS GLU ASN LYS PHE LEU CYS VAL SEQRES 10 A 381 LEU MET SER ASP TRP PHE ASN PHE HIS GLY HIS MET CYS SEQRES 11 A 381 ILE ALA PHE GLU LEU LEU GLY LYS ASN THR PHE GLU PHE SEQRES 12 A 381 LEU LYS GLU ASN ASN PHE GLN PRO TYR PRO LEU PRO HIS SEQRES 13 A 381 VAL ARG HIS MET ALA TYR GLN LEU CYS HIS ALA LEU ARG SEQRES 14 A 381 PHE LEU HIS GLU ASN GLN LEU THR HIS THR ASP LEU LYS SEQRES 15 A 381 PRO GLU ASN ILE LEU PHE VAL ASN SER GLU PHE GLU THR SEQRES 16 A 381 LEU TYR ASN GLU HIS LYS SER CYS GLU GLU LYS SER VAL SEQRES 17 A 381 LYS ASN THR SER ILE ARG VAL ALA ASP PHE GLY SER ALA SEQRES 18 A 381 THR PHE ASP HIS GLU HIS HIS THR THR ILE VAL ALA THR SEQRES 19 A 381 ARG HIS TYR ARG PRO PRO GLU VAL ILE LEU GLU LEU GLY SEQRES 20 A 381 TRP ALA GLN PRO CYS ASP VAL TRP SER ILE GLY CYS ILE SEQRES 21 A 381 LEU PHE GLU TYR TYR ARG GLY PHE THR LEU PHE GLN THR SEQRES 22 A 381 HIS GLU ASN ARG GLU HIS LEU VAL MET MET GLU LYS ILE SEQRES 23 A 381 LEU GLY PRO ILE PRO SER HIS MET ILE HIS ARG THR ARG SEQRES 24 A 381 LYS GLN LYS TYR PHE TYR LYS GLY GLY LEU VAL TRP ASP SEQRES 25 A 381 GLU ASN SER SER ASP GLY ARG TYR VAL LYS GLU ASN CYS SEQRES 26 A 381 LYS PRO LEU LYS SER TYR MET LEU GLN ASP SER LEU GLU SEQRES 27 A 381 HIS VAL GLN LEU PHE ASP LEU MET ARG ARG MET LEU GLU SEQRES 28 A 381 PHE ASP PRO ALA GLN ARG ILE THR LEU ALA GLU ALA LEU SEQRES 29 A 381 LEU HIS PRO PHE PHE ALA GLY LEU THR PRO GLU GLU ARG SEQRES 30 A 381 SER PHE HIS THR HET DKI A1484 28 HET SO4 A1485 5 HET SO4 A1486 5 HET SO4 A1487 5 HET DMS A1488 4 HET DMS A1489 4 HET DMS A1490 4 HET EDO A1491 4 HET EDO A1492 4 HET EDO A1493 4 HET EDO A1494 4 HET CL A1495 1 HET CL A1496 1 HET CL A1497 1 HETNAM EDO 1,2-ETHANEDIOL HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION HETNAM DMS DIMETHYL SULFOXIDE HETNAM DKI 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N- HETNAM 2 DKI (2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1- HETNAM 3 DKI CARBOTHIOAMIDE HETSYN EDO ETHYLENE GLYCOL HETSYN DKI CDK 1/2 INHIBITOR FORMUL 2 EDO 4(C2 H6 O2) FORMUL 3 SO4 3(O4 S 2-) FORMUL 4 CL 3(CL 1-) FORMUL 5 DMS 3(C2 H6 O S) FORMUL 6 DKI C15 H13 F2 N7 O2 S2 FORMUL 7 HOH *307(H2 O) HELIX 1 1 LYS A 193 ASP A 212 1 20 HELIX 2 2 ASN A 242 ASN A 250 1 9 HELIX 3 3 PRO A 256 ASN A 277 1 22 HELIX 4 4 LYS A 285 GLU A 287 5 3 HELIX 5 5 THR A 337 ARG A 341 5 5 HELIX 6 6 PRO A 342 LEU A 347 1 6 HELIX 7 7 GLN A 353 ILE A 360 1 8 HELIX 8 8 CYS A 362 ARG A 369 1 8 HELIX 9 9 GLU A 378 LEU A 390 1 13 HELIX 10 10 PRO A 394 THR A 401 1 8 HELIX 11 11 LYS A 403 PHE A 407 5 5 HELIX 12 12 ARG A 422 CYS A 428 1 7 HELIX 13 13 PRO A 430 MET A 435 5 6 HELIX 14 14 SER A 439 LEU A 453 1 15 HELIX 15 15 THR A 462 LEU A 468 1 7 HELIX 16 16 HIS A 469 ALA A 473 5 5 HELIX 17 17 THR A 476 SER A 481 1 6 SHEET 1 AA 6 TRP A 151 LEU A 152 0 SHEET 2 AA 6 TYR A 156 ILE A 158 -1 O TYR A 156 N LEU A 152 SHEET 3 AA 6 VAL A 170 ASP A 175 -1 O LEU A 174 N GLU A 157 SHEET 4 AA 6 SER A 181 ILE A 187 -1 O SER A 181 N ASP A 175 SHEET 5 AA 6 MET A 232 GLU A 237 -1 O ILE A 234 N LYS A 186 SHEET 6 AA 6 MET A 222 ASN A 227 -1 N SER A 223 O ALA A 235 SHEET 1 AB 2 LEU A 279 THR A 280 0 SHEET 2 AB 2 THR A 325 PHE A 326 -1 O THR A 325 N THR A 280 SHEET 1 AC 2 ILE A 289 PHE A 291 0 SHEET 2 AC 2 ILE A 316 VAL A 318 -1 O ARG A 317 N LEU A 290 SHEET 1 AD 2 PHE A 296 ASN A 301 0 SHEET 2 AD 2 CYS A 306 VAL A 311 -1 O CYS A 306 N ASN A 301 SITE 1 AC1 17 LEU A 162 VAL A 170 ALA A 184 VAL A 220 SITE 2 AC1 17 PHE A 236 GLU A 237 LEU A 239 GLY A 240 SITE 3 AC1 17 LYS A 241 GLU A 245 ASN A 288 LEU A 290 SITE 4 AC1 17 ALA A 319 HOH A2090 HOH A2292 HOH A2293 SITE 5 AC1 17 HOH A2294 SITE 1 AC2 6 ARG A 195 ARG A 199 LYS A 403 LYS A 405 SITE 2 AC2 6 HOH A2295 HOH A2296 SITE 1 AC3 6 ARG A 338 HIS A 377 HOH A2297 HOH A2298 SITE 2 AC3 6 HOH A2299 HOH A2300 SITE 1 AC4 7 GLY A 192 ARG A 338 HOH A2206 HOH A2301 SITE 2 AC4 7 HOH A2302 HOH A2304 HOH A2305 SITE 1 AC5 5 HIS A 330 HIS A 331 LYS A 425 HOH A2245 SITE 2 AC5 5 HOH A2306 SITE 1 AC6 5 HIS A 330 THR A 332 THR A 333 HOH A2175 SITE 2 AC6 5 HOH A2307 SITE 1 AC7 8 ARG A 134 ARG A 272 HIS A 275 THR A 462 SITE 2 AC7 8 LEU A 463 ALA A 464 HOH A2111 HOH A2192 SITE 1 AC8 6 HIS A 339 GLN A 375 THR A 376 HIS A 377 SITE 2 AC8 6 ARG A 400 HOH A2298 SITE 1 AC9 7 GLU A 378 ASN A 379 ARG A 380 LYS A 405 SITE 2 AC9 7 TYR A 406 HOH A2232 HOH A2302 SITE 1 BC1 4 LYS A 140 SER A 395 HIS A 396 HIS A 399 SITE 1 BC2 4 LYS A 140 PRO A 394 SER A 395 HIS A 396 SITE 1 BC3 3 ARG A 189 LYS A 193 TYR A 194 SITE 1 BC4 2 LYS A 206 TRP A 225 SITE 1 BC5 1 TRP A 414 CRYST1 89.150 62.330 74.150 90.00 96.04 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011217 0.000000 0.001187 0.00000 SCALE2 0.000000 0.016044 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013561 0.00000